The outlook of companies tied to the drug's legacy presents a complex investment picture . While the initial surge generated substantial returns , generic copies have significantly eroded sales . Investing in https://whitebookmarks.com/story21708208/copyright-s-flagship-product-and-the-pharmaceutical-sector-a-uncertain-venture